A Chlorinated Diketopiperazine Antibiotic Targets Mycobacterium Tuberculosis DNA Gyrase
Libang LiangiD, Jeffery E. Quigley, Monique E. TheriaultiD, Akira Iinishi, Rachel BargabosiD, Madeleine MorrissetteiD, Megan Ghiglieri, Tom Curtis, Rachel Corsetti, Sangkeun SoniD, Bishwarup Sarkar, Kim LewisiD
Abstract
We describe a novel macrocyclic peptide, speirobactin, produced by Photorhabdus that selectively kills Mycobacterium tuberculosis. A non-ribosomal peptide synthase (NRPS) containing two linear modules codes for the synthesis of speirobactin. The biosynthetic operon contains a pentapeptide-repeat protein as a resistance gene. Genomic analysis of speirobactin-resistant mutants of M. tuberculosis led to identification of DNA gyrase as the molecular target. The mutations were recreated by allelic replacement and show that DNA gyrase is the only target. Transcriptome analysis of M. tuberculosis treated with antibiotics shows that speirobactin clusters close to fluoroquinolones, supporting its action against the DNA gyrase.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus
A. Madani, D. A. Negatu, … T. Dick·bioRxiv·May 16, 2022
- An in silico evaluation of anthraquinone derivatives as potential inhibitors of DNA gyrase B of Mycobacterium tuberculosis
Juliana Carolina Amorim, Andrea E. Cabrera Bermeo, … Juan Marcelo Carpio Arévalo·bioRxiv·Oct 1, 2022
- Dual acting small-Molecule inhibitors targeting Mycobacterial DNA replication
M. Singh, S. Ilic, … B. Akabayov·bioRxiv·Jun 3, 2020
- In Silico Identification of Potential Inhibitors of Mycobacterium tuberculosis DNA Gyrase from Phytoconstituents of Indian Medicinal Plants
Janmejaya Rout, Sayani Das, Sandip Kaledhonkar·Computers in Biology and MedicinePeer-reviewed·Nov 26, 2025
- Assessing Corynebacterium glutamicum as a surrogate of Mycobacterium tuberculosis for DNA gyrase inhibitor design.
Yaëlle Wormser, Emilie Yab, … S. Petrella·bioRxiv·Jun 25, 2026
- Investigating β-lactam drug targets in Mycobacterium tuberculosis using chemical probes
K. E. Beatty, S. R. Levine·bioRxiv·Dec 19, 2019